ArticleMedicine2026
Association of birth weight with general obesity, central obesity, and MASLD in a nationally representative sample of US adolescents: A cross-sectional study from NHANES 1999 to 2020.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic Dysfunction-Associated Steatotic Liver Disease in Childhood: From Disease Heterogeneity to Personalized Care.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Birth weight (BW) may influence subsequent risk of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD); however, the conclusions are controversial and lack exploration in US adolescents. We aimed to explore the association of BW (including low BW [LBW], normal BW [NBW], and high BW [HBW]) with body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and fatty liver index (FLI), as well as general obesity, central obesity, and MASLD, in adolescents using National Health and Nutrition Examination Survey 1999 to 2020. BW was obtained from participants' self-reports. Obesity and MASLD were diagnosed based on their respective specific cutoff values in adolescents. Multivariate linear regression and logistic regression analyses were used to explore these associations and calculate β and odds ratios. A total of 6867 adolescent participants were enrolled. After adjusting for all confounders, BW was positively associated with BMI, WC, WHtR, and FLI (β of 0.639, 1.872, 0.005, and 2.128, respectively). Compared to NBW, HBW was associated with significantly increased BMI, WC, WHtR, and FLI (β of 1.205, 3.387, 0.012, and 4.745, respectively), whereas LBW was not. Similarly, compared to NBW, HBW was associated with significantly increased odds of general obesity, central obesity (as defined by WC/WHtR, respectively), and MASLD (odds ratios 2.629, 1.713, 1.618, and 1.960, respectively). However, LBW was not significantly associated with obesity and steatosis. Race/ethnicity partially influenced these associations. HBW, but not LBW, was associated with increased prevalence of general obesity, central obesity, and MASLD among U.S. adolescents. These findings underscore that adolescents with HBW are at risk for obesity and steatosis and may require early screening and intervention, especially among other Hispanic ethnic groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.